Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review
This systematic review has been framed by pooling the available data on the use of stem cells in SARS-CoV-2. The observations of this systematic review suggest the capability of MSCs in reducing systemic inflammation and protecting against Sars-Cov-2 as evidenced by the available clinical data.

Related Post